Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Tom Selby, director of public policy at AJ Bell, outlines what to watch in the Spring Statement, with no major tax or spending changes expected but potential ...